STAAR Surgical

AI Score

XX

Unlock

17.59
-0.01 (-0.06%)
At close: Apr 02, 2025, 3:59 PM
17.27
-1.82%
After-hours: Apr 02, 2025, 06:29 PM EDT

Company Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.

The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.

It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery.

In addition, the company sells injector parts, and other related instruments and devices.

It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.

The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.

STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical
STAAR Surgical logo
Country United States
IPO Date Feb 24, 1992
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 1,157
CEO Stephen C. Farrell CFA

Contact Details

Address:
25651 Atlantic Ocean Drive
Lake Forest, California
United States
Website https://www.staar.com

Stock Details

Ticker Symbol STAA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000718937
CUSIP Number 852312305
ISIN Number US8523123052
Employer ID 95-3797439
SIC Code 3851

Key Executives

Name Position
Stephen C. Farrell CFA Chief Executive Officer & Lead Director
Deborah J. Andrews Interim Chief Financial Officer
Nancy Sabin Chief Marketing Officer
Warren Foust President & Chief Operating Officer
Brian Moore Vice President of Investor Relations & Corporate Development
Dr. Magda Michna Ph.D. Chief Development Officer and Chief Clinical, Regulatory & Medical Affairs Officer
Dr. Scott D. Barnes M.D. Chief Medical Officer
James Francese Senior Vice President of Commercial Operations - North America & APAC
Nathaniel B. Sisitsky Esq. Senior Vice President, General Counsel & Corporate Secretary
Thomas G. Frinzi Advisor

Latest SEC Filings

Date Type Title
Mar 28, 2025 4 Filing
Mar 28, 2025 SCHEDULE 13G Filing
Mar 25, 2025 4 Filing
Mar 20, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 3 Filing
Mar 18, 2025 8-K Current Report
Mar 14, 2025 4 Filing